| Name | Title | Contact Details |
|---|
Cobalt Sports Holdings was created to provide support, opportunities, collaboration and revenue streams to sports programs by combining the strength in numbers philosophy with clubs that are independent by structure and desire. These are sports programs that want to: Remain independent yet want to build programs that can retain players and coaches Compete at the highest levels Create exposure for players Be relevant at the local, state and national level events Continue to grow within their community. At Cobalt, we believe that EVERY club and EVERY player is relevant. That EVERY club deserves to thrive and that EVERY player should have multiple pathways as well as high-level coaching education opportunities. Pathways to the pros and pathways to college soccer. By combining like minded leaders running independent programs, a superior community of offerings is available to our members.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
MITER Brands is a prominent North American manufacturer of windows and doors, formed in 2022. The company unites well-known brands such as Milgard, MI Windows and Doors, and PGT Innovations, which was acquired in 2024. MITER Brands is dedicated to manufacturing excellence, innovation, and building strong customer relationships. The company produces a wide range of windows and doors, including impact-resistant options designed for safety in extreme weather conditions. MITER Brands emphasizes custom solutions for builders, contractors, and homeowners, focusing on energy efficiency and design flexibility. With a commitment to innovation, the company utilizes proprietary manufacturing technologies and sustainable design practices. MITER Brands serves residential and commercial markets across the nation, aiming to be the most valued window and door brand in America.
American National Bank & Trust is a financial institution with a history dating back to 1856. Originally established as West Omaha National Bank, it has grown to be one of the largest banks in the Midwest, serving clients in Nebraska, Iowa, and Minnesota. The bank focuses on personalized service and building long-term relationships with both business and personal clients. The bank offers a wide range of financial services, including checking and savings accounts, consumer lending, mortgage lending, and construction financing. It also provides trust and investment services, managing approximately $1 billion in assets, and offers real estate title services, equipment and auto leasing, and personal investment services. American National Bank & Trust is committed to fiscal responsibility and conservative banking practices, ensuring financial strength and stability for its customers.